Genmab A/SGMABNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank50
3Y CAGR-5.0%
5Y CAGR-7.2%
Year-over-Year Change
Return on equity
3Y CAGR
-5.0%/yr
vs +2.1%/yr prior
5Y CAGR
-7.2%/yr
Consistent
Acceleration
-7.1pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 17.13% | -19.9% |
| 2024 | 21.38% | +55.3% |
| 2023 | 13.77% | -31.1% |
| 2022 | 19.98% | +50.0% |
| 2021 | 13.32% | -46.5% |
| 2020 | 24.88% | +61.4% |
| 2019 | 15.42% | -16.1% |
| 2018 | 18.37% | +4.4% |
| 2017 | 17.59% | -28.5% |
| 2016 | 24.59% | - |